Landry et al proposed a new TNM staging system for patients with a carcinoid tumor in the colon. The authors are from the University of Louisville.
Parameters:
(1) diameter of the tumor in centimeters
(2) depth of tumor invasion by anatomical layer
(3) regional lymph node metastases
(4) distant metastases
Diameter of Tumor |
Depth of Invasion |
TNM Designation |
<= 1.00 cm |
NA |
T1 |
1.01 to 4.00 cm |
up to and including muscularis propria |
T1 |
1.01 to 4.00 cm |
beyond musclaris propria |
T2 |
> 4.00 cm |
up to and including muscularis propria |
T2 |
> 4.00 cm |
beyond musclaris propria |
T3 |
Parameter |
Finding |
TNM Designation |
regional lymph node metastases |
none |
N0 |
|
>= 1 |
N1 |
distant metastases |
none |
M0 |
|
present |
M1 |
TNM |
Stage |
T1 N0 M0 |
I |
T2 N0 M0 |
II |
T3 N0 M0 |
III |
T1 N1 M0 |
II |
T2 N1 M0 |
II |
T3 N1 M0 |
III |
any M1 |
IV |
Stage |
10 Year Survival |
I |
almost 100% |
II |
75% |
III |
38% |
IV |
16% |
Specialty: Hematology Oncology, Surgery, general, Endocrinology
ICD-10: ,